Instil Bio (TIL.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov14

Instil Bio released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -2.0105 (forecast USD -2.195)

04:00

Instil Bio released FY2025 9 Months earnings on November 13 (EST), actual revenue USD 0, actual EPS USD -9.5703

04:00

Aug14

Instil Bio released FY2025 Semi-Annual earnings on August 13 (EST), actual revenue USD 0, actual EPS USD -7.5543

03:00

Instil Bio released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -3.243 (forecast USD -2.5025)

03:00

Jul2

Instil Bio Receives FDA Approval to Initiate AXN-2510 Clinical Trials

10:04

Jun5

HC Wainwright Reiterates Buy Rating on Instil Bio

11:41

Schedules & Filings

Schedules

Filings

Nov13

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -13.59 M, EPS -2.0105

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -21.39 M, EPS -3.243

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -28.2 M, EPS -4.3167

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More